Skip to main content

View full-text article in PMC

. 2010 Dec 6;83(6):1195–1201. doi: 10.4269/ajtmh.2010.10-0228

Table 1.

Demographics of the study population^*

Cohort	No.	Statistic	Age (years)	Height (cm)	Body weight (kg)	BMI (kg/m²)^†
(+)-mefloquine, 800 mg	8 (4 F, 4 M)	Mean	33.6	169	69.36	24.26
(+)-mefloquine, 800 mg	8 (4 F, 4 M)	Median	36.5	168	68.8	23.95
(+)-mefloquine, 1,600 mg	7 (5 F, 2 M)	Mean	27.4	166	62.56	22.7
(+)-mefloquine, 1,600 mg	7 (5 F, 2 M)	Median	26	166	63.4	21.7
(+)-mefloquine, 1,200 mg	4 (2 F, 2 M)	Mean	39.3	174.3	69.8	22.78
(+)-mefloquine, 1,200 mg	4 (2 F, 2 M)	Median	39	175.5	67	22.7
Placebo	9 (4 F, 5 M)	Mean	32.6	172.7	73.98	24.58
Placebo	9 (4 F, 5 M)	Median	32	176	72.3	25
Racemic mefloquine, 500 mg	8 (6 F, 2 M)	Mean	30.4	168	64.65	22.96
Racemic mefloquine, 500 mg	8 (6 F, 2 M)	Median	29	167	66	22.25
Racemic mefloquine, 1,000 mg	6 (4 F, 2 M)	Mean	28.8	165.7	65.07	23.52
Racemic mefloquine, 1,000 mg	6 (4 F, 2 M)	Median	22	163	64.45	23.15
Racemic mefloquine, 750 mg	4 (3 F, 1 M)	Mean	34.3	167.8	62.78	22.33
Racemic mefloquine, 750 mg	4 (3 F, 1 M)	Median	31.5	166	62.7	22.65

^*

BMI = body mass index.

^†

Mean (SD) BMI for all male and female participants was 23.7 (2.0) kg/m² and 23.3 (2.1) kg/m², respectively.